Wendy Carruthers Boston Scientific Corp (BSX) insider trading activity

Wendy Carruthers is EVP, Human Resources of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 32,028 shares of BSX, which is worth approximately $2.9 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 6,983 shares (Common Stock) at a price of $84.33 per share, resulting in proceeds of $588,876. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32K

14.52% 3M change

31.17% 12M change

Total Value Held $2.9 Million

Wendy Carruthers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2024	SELL Open market or private sale	$588,876 $84.33 p/Share	6,983 Reduced 17.9%	32,028 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 9.85%	39,011 Common Stock
Oct 01 2024	SELL Open market or private sale	$585,594 $83.86 p/Share	6,983 Reduced 16.73%	34,748 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 9.27%	41,731 Common Stock
Sep 03 2024	SELL Open market or private sale	$570,511 $81.7 p/Share	6,983 Reduced 15.71%	37,468 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 8.75%	44,451 Common Stock
Aug 01 2024	SELL Open market or private sale	$517,579 $74.12 p/Share	6,983 Reduced 14.8%	40,188 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 8.29%	47,171 Common Stock
Jul 01 2024	SELL Open market or private sale	$539,785 $77.3 p/Share	6,983 Reduced 14.0%	42,908 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 7.87%	49,891 Common Stock
Jun 03 2024	SELL Open market or private sale	$526,029 $75.33 p/Share	6,983 Reduced 13.27%	45,628 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 7.5%	52,611 Common Stock
May 01 2024	SELL Open market or private sale	$499,075 $71.47 p/Share	6,983 Reduced 12.62%	48,348 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 7.15%	55,331 Common Stock
Apr 01 2024	SELL Open market or private sale	$477,776 $68.42 p/Share	6,983 Reduced 12.03%	51,068 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.84%	58,051 Common Stock
Mar 01 2024	SELL Open market or private sale	$463,322 $66.35 p/Share	6,983 Reduced 11.49%	53,788 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.56%	60,771 Common Stock
Feb 23 2024	SELL Open market or private sale	$467,092 $66.89 p/Share	6,983 Reduced 11.0%	56,508 Common Stock
Feb 23 2024	BUY Exercise of conversion of derivative security	$89,139 $20.91 p/Share	4,263 Added 6.29%	63,491 Common Stock
Feb 20 2024	SELL Bona fide gift	-	3,050 Reduced 4.9%	59,228 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$54,104 $65.82 p/Share	822 Reduced 1.3%	62,278 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	1,853 Added 2.85%	63,100 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$65,688 $65.82 p/Share	998 Reduced 1.6%	61,247 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	2,250 Added 3.49%	62,245 Common Stock

Also insider at

NVST

Envista Holdings Corp Healthcare

Director